Previous close | 119.39 |
Open | 119.37 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 117.98 - 120.72 |
52-week range | 105.31 - 165.03 |
Volume | |
Avg. volume | 1,607,752 |
Market cap | 24.971B |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | 114.68 |
EPS (TTM) | 1.04 |
Earnings date | 01 Aug 2022 - 05 Aug 2022 |
Forward dividend & yield | 0.96 (0.80%) |
Ex-dividend date | 24 Jun 2022 |
1y target est | 131.55 |
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?